CM Life Sciences III Inc. Unit
CMLTU
CMLTU was delisted on the 17th of December, 2021.
0 hedge funds and large institutions have $0 invested in CM Life Sciences III Inc. Unit in 2021 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 28 closing their positions.
100% less funds holding
Funds holding: 28 → 0 (-28)
100% less capital invested
Capital invested by funds: $127M → $0 (-$127M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 28
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$34.3M |
| 2 |
PTC
Petrus Trust Company
Dallas,
Texas
|
-$19M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$13.3M |
| 4 |
PA
Perceptive Advisors
New York
|
-$12.8M |
| 5 |
SHCM
Sachem Head Capital Management
New York
|
-$10.3M |
CMLTU Hedge Fund Activity: Q4 2021 in Review
0 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences III Inc. Unit (CMLTU) for Q4 2021, worth a combined $0 — down 100% from $127M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CMLTU and 0 opened new positions — a net loss of 28 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $34.3M sold.
- 0 institutional investors held CM Life Sciences III Inc. Unit (CMLTU) as of Q4 2021, down from 28 in Q3 2021.
- Funds reported $0 of CM Life Sciences III Inc. Unit stock for Q4 2021, down 100% quarter-over-quarter.
- 0 funds opened new CM Life Sciences III Inc. Unit positions in Q4 2021 and 28 closed out, a net change of -28 holders.
- The largest CM Life Sciences III Inc. Unit seller in Q4 2021 was T. Rowe Price Associates, an estimated $34.3M sold.
Based on aggregated 13F filings for Q4 2021.